CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas

Biochemical and Biophysical Research Communications

Volumn 407, Issue 4, 2011, Pages 741-746

  Kim, Seong Muk ^b   Kim, Dal Soo ^a   Jeong, Chang Hyun ^b   Kim, Dong Hyun ^a   Kim, Ji Hyun ^a   Jeon, Hong Bae ^a   Kwon, Soon Jae ^a   Jeun, Sin Soo ^b   Yang, Yoon Sun ^a   Oh, Wonil ^a   Chang, Jong Wook ^a  

^a MEDIPOST Co Ltd   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

CXCR1; Glioma; In vivo imaging; Tumor tropism; Umbilical cord blood derived mesenchymal stem cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; INTERLEUKIN 8; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CYTOKINE RELEASE; GLIOMA; GLIOMA CELL; HISTOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELL;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FETAL BLOOD; GENE KNOCKDOWN TECHNIQUES; GENE THERAPY; GLIOMA; HUMANS; INTERLEUKIN-8; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; RECEPTORS, INTERLEUKIN-8A; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 79954997170     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.093     Document Type: Article

References (24)

1. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49. (PubMed: 12077603).
2. Mareschi K., Ferrero I., Rustichelli D., Aschero S., Gammaitoni L., Aglietta M., Madon E., Fagioli F. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J. Cell Biochem. 2006, 97:744-754. (PubMed: 16229018).
3. Flynn A., Barry F., O'Brien T. UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 2007, 9:717-726. (PubMed: 17917891).
4. Secco M., Zucconi E., Vieira N.M., Fogaca L.L., Cerqueira A., Carvalho M.D., Jazedje T., Okamoto O.K., Muotri A.R., Zatz M. Multipotent stem cells from umbilical cord: cord is richer than blood. Stem Cells 2008, 26:146-150. (PubMed: 17932423).
5. Kim S.M., Lim J.Y., Park S.I., Jeong C.H., Oh J.H., Jeong M., Oh W., Park S.H., Sung Y.C., Jeun S.S. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res. 2008, 68:9614-9623. (PubMed: 19047138).
6. Kim D.S., Kim J.H., Lee J.K., Choi S.J., Kim J.S., Jeun S.S., Oh W., Yang Y.S., Chang J.W. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev. 2009, 18:511-519. (PubMed: 18624673).
7. Kim S.M., Oh J.H., Park S.A., Ryu C.H., Lim J.Y., Kim D.S., Chang J.W., Oh W., Jeun S.S. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells 2010, 28:2217-2228. (PubMed: 20945331).
8. Ryu C.H., Park S.H., Park S.A., Kim S.M., Lim J.Y., Jeong C.H., Yoon W.S., Oh W.I., Sung Y.C., Jeun S.S. Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells. Hum. Gene Ther. 2011, (PubMed: 21261460).
9. Brat D.J., Bellail A.C., Van Meir E.G. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005, 7:122-133. (PubMed: 15831231).
10. Kim J.Y., Kim D.H., Kim D.S., Kim J.H., Jeong S.Y., Jeon H.B., Lee E.H., Yang Y.S., Oh W., Chang J.W. Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro. FEBS Lett. 2010, 584:3601-3608. (PubMed: 20655311).
11. Lim J.Y., Park S.H., Jeong C.H., Oh J.H., Kim S.M., Ryu C.H., Park S.A., Ahn J.G., Oh W., Jeun S.S., Chang J.W. Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells. BMC Biotechnol. 2010, 10:38. (PubMed: 20462460).
12. Murphy P.M., Tiffany H.L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991, 253:1280-1283. (PubMed: 1891716).
13. Holmes W.E., Lee J., Kuang W.J., Rice G.C., Wood W.I. Structure and functional expression of a human interleukin-8 receptor. Science 1991, 253:1278-1280. (PubMed: 1840701).
14. Sasportas L.S., Kasmieh R., Wakimoto H., Hingtgen S., van de Water J.A., Mohapatra G., Figueiredo J.L., Martuza R.L., Weissleder R., Shah K. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc. Natl. Acad. Sci. USA 2009, 106:4822-4827. (PubMed: 19264968).
15. Bexell D., Gunnarsson S., Tormin A., Darabi A., Gisselsson D., Roybon L., Scheding S., Bengzon J. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol. Ther. 2009, 17:183-190. (PubMed: 18985030).
16. Sonabend A.M., Ulasov I.V., Tyler M.A., Rivera A.A., Mathis J.M., Lesniak M.S. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells 2008, 26:831-841. (PubMed: 18192232).
17. Birnbaum T., Roider J., Schankin C.J., Padovan C.S., Schichor C., Goldbrunner R., Straube A. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J. Neurooncol. 2007, 83:241-247. (PubMed: 17570034).
18. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., Chen J., Hentschel S., Vecil G., Dembinski J., Andreeff M., Lang F.F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005, 65:3307-3318. (PubMed: 15833864).
19. Hamada H., Kobune M., Nakamura K., Kawano Y., Kato K., Honmou O., Houkin K., Matsunaga T., Niitsu Y. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci. 2005, 96:149-156. (PubMed: 15771617).
20. Nakamura K., Ito Y., Kawano Y., Kurozumi K., Kobune M., Tsuda H., Bizen A., Honmou O., Niitsu Y., Hamada H. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004, 11:1155-1164. (PubMed: 15141157).
21. Kim J.Y., Jeon H.B., Yang Y.S., Oh W., Chang J.W. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. World J. Stem Cells 2010, 2:34-38.
22. Mazzini L., Ferrero I., Luparello V., Rustichelli D., Gunetti M., Mareschi K., Testa L., Stecco A., Tarletti R., Miglioretti M., Fava E., Nasuelli N., Cisari C., Massara M., Vercelli R., Oggioni G.D., Carriero A., Cantello R., Monaco F., Fagioli F. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a Phase I clinical trial. Exp. Neurol. 2010, 223:229-237. (PubMed: 19682989).
23. Jiang Q., Zhang Z.G., Ding G.L., Zhang L., Ewing J.R., Wang L., Zhang R., Li L., Lu M., Meng H., Arbab A.S., Hu J., Li Q.J., Pourabdollah Nejad D.S., Athiraman H., Chopp M. Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. Neuroimage 2005, 28:698-707. (PubMed: 16112879).
24. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., Gowda-Kurkalli B., Gomori J.M., Kassis I., Bulte J.W., Petrou P., Ben-Hur T., Abramsky O., Slavin S. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 2010, 67:1187-1194. (PubMed: 20937945).